Risk for Parkinson's disease: Twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET

Journal of Neurology, Supplement

Volumn 247, Issue 2, 2000, Pages 110-113

  Laihinen, Arto ^a   Ruottinen, Hanna ^a   Rinne, Juha O ^a   Haaparanta, Merja ^a   Bergman, Jörgen ^a   Solin, Olof ^a   Koskenvuo, Markku ^a   Marttila, Reijo ^a   Rinne, Urpo K ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Fluorodopa; Heredity; Parkinson's disease; PET; Twins

Indexed keywords

AMANTADINE; BROMOCRIPTINE; DOPA; FLUORINE 18; LEVODOPA; ORPHENADRINE; PERGOLIDE; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; AGED; CAUDATE NUCLEUS; CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DIZYGOTIC TWINS; DOPAMINERGIC SYSTEM; FEMALE; FINLAND; HUMAN; MALE; MONOZYGOTIC TWINS; NORMAL HUMAN; OCCIPITAL CORTEX; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RISK;

ANALYSIS OF VARIANCE; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; MALE; PARKINSON DISEASE; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034090879     PISSN: 09391517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Allan W (1937) Inheritance of the shaking palsy. Arch Intern Med 60: 424-436
2. Bell J, Clark AJ (1926) A pedigree of paralysis agitans. Ann Eugen 1:445-462
3. Ben-Shlomo Y (1996) How far are we in understanding the cause of Parkinson's disease: a reappraisal. J Neurol Neurosurg Psychiatry 61:4-16
4. 18F] fluoride. J Lab Compd Radiopharm 35:476-477
5. Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, Bannister R, Marsden CD, Frackowiak RS (1990) Differing patterns of striatal 18F-Dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 28:547-555
6. 18F-dopa and positron emission tomography. Neurology 42:1894-1900
7. Duvoisin RC (1986) On heredity, twins, and Parkinson's disease. Ann Neurol 19:409-411
8. Duvoisin RC, Eldridge R, Williams A, Nutt J, Calne DB (1981) Twin study of Parkinson disease. Neurology 31:77-80
9. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease. MacMillan Healthcare Information Florham Park, NJ, pp 153-163
10. Gasser T, Müller-Myhsok B, Wszolke ZK, Durr A, Vaughan JR, Bonifati V, Meco G, Bereznai B, Oehlmann R, Agid Y, Brice A, Wood N (1997) Genetic complexity and Parkinson's disease. Science 277:387-388.
11. Holtoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K, Bonner J, Wagner R, Wienhard K, Pawlik G, Heiss WD (1994) Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neural 36:176-182
12. 18F-DOPA metabolism in living human brain: a comparison of six analytical methods. J Cereb Blood Flow Metab 13:57-69
13. Jankovic J, Reches A (1986) Parkinson's disease in monozygotic twins. Ann Neurol 19:405-408
14. Kaprio J, Sarna S, Koskonvuo M, Rantasalo I (1978) The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedures and research programs. In: Nance W. Twin research: biology and epidemiology. Prog Clin Biol Res 24B:179-184
15. Koller W, O'Hara R, Nutt J, Young J, Rubino F (1986) Monozygotic twins with Parkinson's disease. Ann Neurol 19:402-405
16. Langston JW (1996) The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology 47(suppl 3):S153-S160
17. Marsden CD (1987) Parkinson's disease in twins. J Neurol Neurosurg Psychiatry 50:105-106
18. Marttila RJ, Kaprio J, Koskenvuo M, Rinne UK (1988) Parkinson's disease in a nationwide twin cohort. Neurology 38:1217-1219
19. Mjönes H (1949) Paralysis agitans: a clinical and genetic study. Acta Psychiatr Neurol (suppl 54):1-195
20. 18F]fluoro-L-dopa. Int J Appl Radiat Isot 43:989-996
21. 18F-dopa positron emission tomography study. Ann Neurol 41: 222-229
22. Polymeropoulos MH (1997) Genetic complexity and Parkinson's disease [letter]. Science 277:389
23. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Strenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC (1996) Mapping of a gene for Parkinson's disease to chromosone 4q21-q23. Science 274:1197-1199
24. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin C, Di Iorio G, Golbe LI, Bussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
25. Sarnu S, Kaprio J, Sistonen P, Koskenvuo M (1978) Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 28:241-254
26. Sawle GV, Wroe SJ, Lees AJ, Brooks DJ, Frackowiak RS (1992) The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred. Ann Neurol 32:609-617
27. Schapira A (1994) Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal. Mov Disord 9:125-138
28. Scott WK, Stajich JM, Yamaoka LH, Speer MC, Vance JM, Roses AD, Pericak-Vance MA, Polymeropoulos MH (1997) Genetic complexity and Parkinson's disease [letter]. Science 277:387-389
29. Vontobel P, Künig G. Brühlmeier M, Günther I, Leenders KL (1996) Influence of large neutral amino acid (LNAA) blood concentration variations on 18F-DOPA quantification. Annual Report 1996, Annex II, PSI Life Sciences and Institute for Medical Radiobiology. PSI Information Group, Paul Sherrer Institut, Villigen, Switzerland, p 76
30. Ward CD, Duvoisin RC, Ince SE, Nut JG. Eldridge R, Calne DB (1983) Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 33:815-824
31. Wood N (1997) Genes and parkinsonism. J Neurol Neurosurg Psychiatry 62:305-309
32. Zimmerman TR, Bhatt M, Calne DB, Duvoisin RC (1991) Parkinson's disease in monozygotic twins: a follow-up [abstract]. Neurology 41 (suppl 1):255